Commit Biologics

Aarhus, Denmark

Commit Biologics is a biotechnology research company developing a novel immunotherapy platform for the treatment of cancer.

$5.7M raised

Jan 2025

Seed

Biotechnology Life Science Medical Therapeutics

Top Investors

Novo HoldingsKorysBioqube VenturesInnovation Fund DenmarkBioInnovation Institute

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Commit Biologics

How much funding has Commit Biologics raised?

Commit Biologics has raised $5.7M in total funding. The most recent round was Seed. The last funding was announced in January 2025.

Who are Commit Biologics's investors?

Commit Biologics's investors include Novo Holdings, Korys, Bioqube Ventures, Innovation Fund Denmark, BioInnovation Institute.

Where is Commit Biologics headquartered?

Commit Biologics is headquartered in Aarhus, Denmark.

What does Commit Biologics do?

Commit Biologics is a biotechnology research company developing a novel immunotherapy platform for the treatment of cancer.

What stage is Commit Biologics at?

Commit Biologics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 28, 2025.

MLA

"Commit Biologics — Funding & Investors." VCBacked, January 28, 2025, https://www.vcbacked.co/company/commit-biologics. Accessed June 7, 2026.

APA

VCBacked. (2025). Commit Biologics — Funding & Investors. Retrieved June 7, 2026, from https://www.vcbacked.co/company/commit-biologics

Wikipedia (cite web)

{{cite web |title=Commit Biologics — Funding & Investors |url=https://www.vcbacked.co/company/commit-biologics |website=VCBacked |access-date=June 7, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 28, 2025.

Similar Companies in Biotechnology